消化器空间的初级粘膜皮质癌呈现与严重肌衰竭
Mitchell Boshkos1, Sreya Rahman2, Dharani Narendra2
1Department of Hospital Medicine, MD Anderson Cancer Center Track, Baylor College of Medicine, Houston, TX, USA.
Case reports in oncology
|October 9, 2025
概括
这项研究强调了一例罕见的肌痛性肌肉癌 (MEC) 患者的肌痛性肌肉癌 (MG) 病例,这是唾液腺恶性瘤. 它强调了非胸腺癌引发神经瘤性MG的潜力,表明需要提高临床意识.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性神经肌肉疾病,通常与胸腺瘤有关.
- 与非胸膜恶性瘤相关的MG很少被报告.
- 粘膜皮质腺癌 (MEC) 是一种唾液腺癌,是未被充分认识到的副瘤性MG的潜在触发因素.
研究的目的:
- 呈现一种罕见的新发性肌痛性肌痛症 (MG) 病例,患者同时被诊断患有粘膜皮质癌 (MEC).
- 为了强调非胸膜恶性瘤,特别是头癌 (如MEC) 和副瘤性MG之间的关联.
- 为了提高临床意识,关于这个未被认可的副瘤综合征.
主要方法:
- 一个24岁的女性病例介绍,她的神经症状逐渐恶化.
- 诊断工作包括体检,成像 (部和胸部的CT扫描),活检和对乙胆受体抗体的血清学测试.
- 治疗涉及经验性血交换可疑的肌危机.
主要成果:
- 患者出现了MG的症状,包括ptosis,面部和部软弱,消化不良和呼吸不充分.
- 图像检测显示左口腔空间质量被诊断为MEC;没有检测到胸腺瘤.
- 血清测试证实MG具有阳性乙胆受体抗体,血交换导致临床改善.
结论:
- 在MG症状和MEC诊断之间的时间关联表明了副瘤病因.
- 这一病例代表了少数记录下来的与MEC相关的副瘤性MG病例之一,MEC是一种非胸腺恶性瘤.
- 进一步的研究是有必要的,以建立一个直接的联系,并了解瘤切除解决MG症状的潜力.
更多相关视频
07:09Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
14.0K
19:53Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
106.4K
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Chemical Synapses
11.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.3K
Chemical Synapses
4.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.3K
Cholinergic Receptors: Muscarinic
4.8K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
4.8K
